BLOOD LEVEL AND URINARY-EXCRETION OF ACTIVATED CYCLOPHOSPHAMIDE AND ITS DEACTIVATION PRODUCTS IN MAN

被引：57

作者：

WAGNER, T

HEYDRICH, D

VOELCKER, G

HOHORST, HJ

机构：

[1] STADT KRANKENHAUS,MED KLIN,D-2400 LUBECK,FED REP GER

[2] UNIV FRANKFURT,GUSTAV EMBDEN ZENTRUM BIOL CHEM,D-6000 FRANKFURT 70,FED REP GER

来源：

关键词：

D O I：

10.1007/BF00412899

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：79 / 92

页数：14

共 33 条

[1]

BAGLEY CM, 1973, CANCER RES, V33, P226

[2]

BROCK N, 1971, CANCER, V27, P1512, DOI 10.1002/1097-0142(197106)27:6<1512::AID-CNCR2820270636>3.0.CO

[3]

2-Q

[4]

BROCK N, 1979, ARZNEIMITTEL-FORSCH, V29-1, P659

[5]

BROCK N, 1976, CANCER TREAT REP, V60, P301

[6]

BROCK N, 1977, Zeitschrift fuer Krebsforschung und Klinische Onkologie, V88, P185

[7]

BROCK N, 1963, ARZNEIMITTEL-FORSCH, V13, P1021

[8]

CARTER SK, 1977, 45 NAT CANC I MON, P63

[9]

CHARGAFF E, 1948, J BIOL CHEM, V175, P67

[10] PHARMACOKINETICS OF CYCLOPHOSPHAMIDE IN MAN [J].

COHEN, JL ;

JAO, JY ;

JUSKO, WJ .